Global Antihistamine Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antihistamine Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antihistamines are a class of drugs that inhibit the action of histamine by attacking the specific cell receptors meant for histamines. Histamine is an immune substance released by body’s immune system upon attack by allergens or due to intake of histamine-deficient food, some food items also trigger their excessive production which creates immune response.
Antihistamine Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antihistamine Drugs market is projected to reach US$ 292.8 million in 2034, increasing from US$ 194.5 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antihistamine Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antihistamine Drugs key manufacturers include Bayer, Almirall, Meda Consumer Healthcare, AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Pfizer and Boehringer Ingelheim, etc. Bayer, Almirall, Meda Consumer Healthcare are top 3 players and held % sales share in total in 2022.
Antihistamine Drugs can be divided into Prescription-based Antihistamine Drugs and Over-the-counter(OTC) Antihistamine Drugs, etc. Prescription-based Antihistamine Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Antihistamine Drugs is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Antihistamine Drugs industry development. In 2022, global % sales of Antihistamine Drugs went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihistamine Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report
Bayer
Almirall
Meda Consumer Healthcare
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Pfizer
Boehringer Ingelheim
Akorn
Merck & Co.
Teva Pharmaceutical
Segment by Type
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antihistamine Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antihistamine Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antihistamine Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antihistamine Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antihistamine Drugs introduction, etc. Antihistamine Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antihistamine Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Antihistamine Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antihistamine Drugs market is projected to reach US$ 292.8 million in 2034, increasing from US$ 194.5 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antihistamine Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antihistamine Drugs key manufacturers include Bayer, Almirall, Meda Consumer Healthcare, AstraZeneca, Johnson & Johnson, Novartis, Sanofi, Pfizer and Boehringer Ingelheim, etc. Bayer, Almirall, Meda Consumer Healthcare are top 3 players and held % sales share in total in 2022.
Antihistamine Drugs can be divided into Prescription-based Antihistamine Drugs and Over-the-counter(OTC) Antihistamine Drugs, etc. Prescription-based Antihistamine Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Antihistamine Drugs is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Antihistamine Drugs industry development. In 2022, global % sales of Antihistamine Drugs went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihistamine Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sale Channel and Regions Listed in the Report
By Company
Bayer
Almirall
Meda Consumer Healthcare
AstraZeneca
Johnson & Johnson
Novartis
Sanofi
Pfizer
Boehringer Ingelheim
Akorn
Merck & Co.
Teva Pharmaceutical
Segment by Type
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Segment by Sale Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antihistamine Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antihistamine Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antihistamine Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antihistamine Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sale Channel, Volume and Revenue analysis of Each Sale Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antihistamine Drugs introduction, etc. Antihistamine Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antihistamine Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices